Janney Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$16.6M Sell
172,804
-4,093
-2% -$398K 1.04% 27
2025
Q3
$16.8M Sell
176,897
-1,904
-1% -$175K 1.05% 26
2025
Q2
$15.6M Sell
178,801
-2,292
-1% -$194K 1.01% 24
2025
Q1
$16.3M Sell
181,093
-5,446
-3% -$487K 1.12% 22
2024
Q4
$14.9M Sell
186,539
-8,203
-4% -$710K 0.99% 31
2024
Q3
$17.5M Sell
194,742
-2,167
-1% -$182K 1.18% 20
2024
Q2
$15.5M Sell
196,909
-9,967
-5% -$817K 1.09% 23
2024
Q1
$18M Buy
206,876
+885
+0.4% +$75.5K 1.2% 17
2023
Q4
$17M Buy
205,991
+18,476
+10% +$1.41M 1.14% 25
2023
Q3
$14.7M Buy
187,515
+2,799
+2% +$234K 1.13% 25
2023
Q2
$16.3M Buy
184,716
+2,495
+1% +$215K 1.13% 26
2023
Q1
$14.7M Buy
182,221
+39,190
+27% +$3.19M 1.11% 29
2022
Q4
$11.1M Buy
143,031
+35,973
+34% +$2.92M 0.79% 46
2022
Q3
$8.64M Buy
107,058
+86,704
+426% +$7.79M 0.7% 60
2022
Q2
$1.83M Buy
20,354
+981
+5% +$99.4K 0.15% 94
2022
Q1
$2.15M Buy
19,373
+7,308
+61% +$772K 0.15% 93
2021
Q4
$1.25M Buy
12,065
+432
+4% +$50K 0.08% 112
2021
Q3
$1.46M Buy
11,633
+101
+0.9% +$13.1K 0.1% 110
2021
Q2
$1.43M Buy
11,532
+226
+2% +$28.4K 0.09% 115
2021
Q1
$1.34M Sell
11,306
-161
-1% -$18.9K 0.09% 114
2020
Q4
$1.34M Buy
11,467
+36
+0.3% +$3.96K 0.09% 108
2020
Q3
$1.19M Buy
11,431
+2,404
+27% +$241K 0.08% 118
2020
Q2
$828K Buy
9,027
+1,498
+20% +$144K 0.06% 119
2020
Q1
$679K Buy
7,529
+1,114
+17% +$119K 0.05% 110
2019
Q4
$728K Buy
6,415
+301
+5% +$33K 0.04% 122
2019
Q3
$664K Buy
6,114
+2,197
+56% +$229K 0.04% 117
2019
Q2
$381K Buy
3,917
+449
+13% +$41K 0.02% 151
2019
Q1
$316K Buy
3,468
+366
+12% +$32.8K 0.02% 164
2018
Q4
$282K Sell
3,102
-650
-17% -$60.7K 0.02% 166
2018
Q3
$369K Buy
3,752
+740
+25% +$68.4K 0.02% 173
2018
Q2
$258K Buy
+3,012
New +$252K 0.01% 191
2017
Q1
Sell
-205,467
Closed -$14.6M 192
2016
Q4
$14.6M Sell
205,467
-28,749
-12% -$2.26M 0.67% 58
2016
Q3
$20.2M Sell
234,216
-18,303
-7% -$1.59M 0.91% 45
2016
Q2
$21.9M Sell
252,519
-2,706
-1% -$219K 1.16% 26
2016
Q1
$19.1M Sell
255,225
-2,868
-1% -$216K 1.03% 42
2015
Q4
$19.9M Buy
258,093
+2,094
+0.8% +$158K 0.87% 44
2015
Q3
$17.1M Buy
+255,999
New +$18.9M 0.78% 54
2015
Q2
Sell
-244,466
Closed -$19.1M 127
2015
Q1
$19.1M Buy
244,466
+4,113
+2% +$312K 0.64% 62
2014
Q4
$17.4M Buy
240,353
+13,034
+6% +$905K 1% 42
2014
Q3
$14.1M Buy
227,319
+5,835
+3% +$371K 0.85% 62
2014
Q2
$14.1M Buy
221,484
+8,507
+4% +$517K 0.85% 62
2014
Q1
$13.1M Buy
212,977
+23,351
+12% +$1.36M 0.87% 58
2013
Q4
$10.9M Buy
189,626
+8,769
+5% +$497K 0.8% 64
2013
Q3
$9.63M Buy
180,857
+5,514
+3% +$297K 0.79% 59
2013
Q2
$9.03M Buy
+175,343
New +$8.67M 0.89% 57

Other funds holding MDT

Janney Capital Management's MDT Position: Q4 2025 in Review

Janney Capital Management reduced its Medtronic (MDT) stake by 2.3% in Q4 2025, selling an estimated $398K and leaving 172,804 shares worth $16.6M. The position accounts for 1.04% of the portfolio, ranked #27.

Janney Capital Management first reported a position in MDT in Q2 2013 and has held it in 45 quarters since. The position peaked at $21.9M in Q2 2016. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Janney Capital Management held 172,804 shares of Medtronic worth $16.6M as of Q4 2025.
  • Janney Capital Management sold 4,093 Medtronic shares in Q4 2025, an estimated $398K.
  • Medtronic made up 1.04% of Janney Capital Management's portfolio in Q4 2025, its #27 holding.
  • Janney Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 45 quarters since.
  • Janney Capital Management's Medtronic position peaked at $21.9M in Q2 2016.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Janney Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.